RxDoctor Payments Data

Donald McNicol

Pulmonary Disease · Norwalk, CTNPI 1912920034

Payments from drug & device makers

$1,788in general payments, 2019–2025

Across 107 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$405
  • AstraZeneca$398
  • Merck$241
  • Biohaven Pharmaceutical Holding Company Ltd.$171
  • Lilly USA, LLC$156
  • Novo Nordisk$83
  • plus $334 from 13 others

What the payments were for

  • Food & beverage$1,788100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,788 in reported general payments places this provider in the 55th percentile of 255 pulmonary disease providers in Connecticut.

See all pulmonary disease providers in Connecticut

Other pulmonary disease in Norwalk

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →